Bruno Strigini - Novartis Oncology
Last quote by Bruno Strigini
Through this collaboration with IBM Watson Health, we will use real-world breast cancer data and cognitive computing to identify solutions that may help physicians better understand which therapy may be best for which patients or advise clinical practice guidelines. We hope this collaboration also uncovers care efficiencies that can be applied beyond breast cancer.feedback
Jun 05 2017
This page is completely dedicated to what Bruno Strigini has to say. All of Bruno Strigini’s quotes are organized here by date and topic. The most recent quote attributed to Bruno Strigini came from an article called Novartis leukemia drug wins FDA priority review: “FLT3-mutated AML and advanced SM are devastating and rare diseases, with significant unmet needs due to limited existing treatment options.”.
Take our quote verification challenge and find out !
Quotes by Bruno Strigini
Nov 14 2016
FLT3-mutated AML and advanced SM are devastating and rare diseases, with significant unmet needs due to limited existing treatment options.feedback
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided